2606 67. Sijens PE, Smit GP, Borgdorff MAJ, Kappert P, Oudkerk M (2006) Multiple voxel 1H MR spectroscopy of phos- phorylase-b kinase deficient patients (GSD IXa) showing an accumulation of fat in the liver that resolves with aging. J Hepatol 45:851–855 68. Irwan R, Edens MA, Sijens PE (2008) Assessment of the variations in fat content in normal liver using a fast quantification MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol 18:806–813 69. Johnson NA, Walton DW, Sachinwalla T, Thompson CH, Smith K, Ruell PA, Stannard SR, George J (2008) Non- invasive assessment of hepatic lipid composition: advancing understanding and management of fatty liver disor- ders. Hepatology 47:1513–1523 70. Dixon WT (1984) Simple proton spec- troscopic imaging. Radiology 153:189– 194 71. Hussain HK, Chenevert TL, Londy FJ, Gulani V, Swanson SD, McKenna BJ, Appelman HD, Adusumilli S, Greenson JK, Conjeevaram HS (2005) Hepatic fat fraction: MR imaging for quantitative measurement and display—early experience. Radiology 237:1048–1055 72. O’Regan DP, Callaghan MF, Wylezinska-Arridge M, Fitzpatrick J, Naoumova RP, Hajnal JV, Schmitz SA (2008) Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T—feasibility. Radiology 247:550– 557 73. Guiu B, Loffroy R, Cercueil JP, Krause D (2008) Multiecho MR imaging and proton MR spectroscopy for liver fat quantification (letter-to-the-editor). Ra- diology 249:1081 74. Xiang QS (2006) Two-point water-fat imaging with partially opposed-phase (POP) acquisition: an asymmetric Dixon method. Magn Reson Med 56:572–584 75. Paltiel Z (1985) Separate water and lipids images obtained by a single scan. In: Proceedings of the 4th Annual Meeting of SMRM, New York, USA, pp 172–173 76. Patrick JL, Haacke EM, Hahn JE (1985) Water fat separation and chem- ical shift artefact correction using a single scan. In: Proceedings of the 4th Annual Meeting of SMRM, New York, USA, pp 174–175 77. Ahn CB, Lee SY, Nalcioglu O, Cho ZH (1986) Spectroscopic imaging by quadrature modulated echo time shift- ing. Magn Reson Imaging 4:110–111 78. Xiang QS, An L (1997) Water-fat imaging with direct phase encoding. J Magn Reson Imaging 7:1002–1015 79. Cottler SJ, Guzman G, Layden-Almer J, Mazzone T, Layden TJ, Zhou XJ (2007) Measurement of liver fat content using selective saturation at 3.0 T. J Magn Reson Imaging 25:743–748 80. Machan J, Thamer C, Schnoedt B, Stefan N, Haring H-U, Claussen CD, Frische A, Schick F (2006) Hepatic lipid accumulation in healthy subjects: a comparative study using spectral fat- selective MRI and volume-localized 1H-MR spectroscopy. Magn Reson Med 55:913–917 81. Sijens PE, Oudkerk M (2005) Clinical magnetic resonance spectroscopy. Im- aging Decis MRI 9:39–48 82. Sijens PE, Dagnelie PC, Halfwerk S, van Dijk P, Wicklow K, Oudkerk M (1998) Understanding the discrepancies between 31P MR spectroscopy as- sessed liver metabolite concentrations from different institutions. Magn Reson Imaging 16:205–211 83. Buchli R, Meier D, Martin E, Boesiger P (1994) Assessment of absolute me- tabolite concentrations in human tissue by 31P MRS in vivo. Magn Reson Med 32:453–458 84. Norén B, Lundberg P, Ressner M, Wirell S, Almer S, Smedby O (2005) Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease. Eur Radiol 15:148–157 85. Cox IJ, Couts GA, Gadian DG, Ghosh P, Sargentoni J, Young IR (1991) Saturation effects in phosphorus-31 magnetic resonance spectra of the human liver. Magn Reson Med 17:53– 61 86. Sijens PE, van Dijk P, Dagnelie PC, Oudkerk M (1995) Non-T1 weighted 31P MR chemical shift imaging of the human liver. Magn Reson Imaging 13:621–628 87. Li CW, Negendank WG, Murphy- Boesch J, Padavic-Shaller K, Brown TR (1996) Molar quantitation of he- patic metabolites in vivo proton-de- coupled, nuclear Overhauser effect enhanced 31P NMR spectra localized by three-dimensional chemical shift imaging. NMR Biomed 9:141–155 88. Schlemmer H-P, Sawatzki T, Sammet S, Dornacher I, Bachert P, van Kaick G, Waldherr R, Seitz HK (2005) Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy. J Hepatol 42:752–759 89. Menon DK, Sargentoni J, Taylor- Robinson SD, Bell JD, Cox IJ, Bryant DJ, Coutts GA, Rolles K, Burroughs AK, Morgan MY (1995) Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appear- ances. Hepatology 21:417–427 90. van Wassenaer-van Hall HN, van der Grond J, van Hattum J, Kooijman C, Hoogenraad TU, Mali WP (1995) 31P magnetic resonance spectroscopy of the liver: correlation with standardized serum, clinical, and histological changes in diffuse liver disease. Hepa- tology 21:443–449 91. Dezortova M, Taimr A, Skoch A, Spicak J, Hajek M (2005) Etiology and functional status of liver cirrhosis by 31P MR spectroscopy. World J Gastroenterol 11:6926–6931 92. Lim AKP, Patel N, Hamilton G, Mylvahan K, Kuo Y-T, Goldin RD, Taylor-Robinson SD (2007) 31P MR spectroscopy in assessment of response to antiviral therapy for hepatitis C virus-related liver disease. Am J Roentgenol AJR 189:819–823 93. Norén B, Dahlquist O, Lundberg P, Almer S, Kechagias S, Ekstedt M, Franzèn L, Wirell S, Smedby O (2008) Separation of advanced from mild cir- rhosis in diffuse liver disease using 31P magnetic resonance spectroscopy. Eur Radiol 15:148–157 94. Lim AKP, Patel N, Hamilton G, Goldin RD, Hajnal JV, Taylor-Robinson SD (2003) Findings at 31P magnetic reso- nance spectroscopy correlate with his- tology in chronic hepatitis C virus infection. Hepatology 27:788–794 95. Sharma R, Sinha S, Danishad KA, Vikram NK, Gupta A, Ahuja V, Jagannathan NR, Pandey RM, Misra A (2009) Investigation of hepatic gluco- neogenesis pathway in non-diabetic Asian Indians with non-alcoholic fatty liver disease using in vivo (31P) phos- phorus magnetic resonance spectrosco- py. Atherosclerosis 203(1):291–297. doi: 10.1016/j.atherosclero sis.2008.06.016 96. Dagnelie PC, Sijens PE, Kraus DJ, Planting AS, van Dijk P (1999) Ab- normal liver metabolism in cancer patients detected by 31P MR spectros- copy. NMR Biomed 12:535–544 97. Leij-Halfwerk S, Dagnelie PC, Kappert P, Oudkerk M, Sijens PE (2000) Decreased hepatic energy and phos- phorylation status in the liver of advanced lung cancer patients with weight loss. J Hepatol 32:887–892